Trial · NCT03770000
Results by group22
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 22
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose escalation_Cohort 1 | No.of Participants with Dose Limiting Toxicities | 0 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose escalation_Cohort 2 | No.of Participants with Dose Limiting Toxicities | 0 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose escalation_Cohort 3 | No.of Participants with Dose Limiting Toxicities | 0 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose expansion_Group 1 (PTCL) | No.of Participants with Dose Limiting Toxicities | 0 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose expansion_Group 2 (CTCL) | No.of Participants with Dose Limiting Toxicities | 0 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose escalation_Cohort 1 | No.of Participants without Dose Limiting Toxicities | 3 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose escalation_Cohort 2 | No.of Participants without Dose Limiting Toxicities | 3 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose escalation_Cohort 3 | No.of Participants without Dose Limiting Toxicities | 3 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose expansion_Group 1 (PTCL) | No.of Participants without Dose Limiting Toxicities | 0 | Participants | |
| Number of Participants With and Without Dose Limiting Toxicities (DLTs) | Dose expansion_Group 2 (CTCL) | No.of Participants without Dose Limiting Toxicities | 0 | Participants | |
| Overall Response Rate (ORR) With Tenalisib and Romidepsin Combination | Dose escalation_Cohort 1 | 2 | Participants | ||
| Overall Response Rate (ORR) With Tenalisib and Romidepsin Combination | Dose escalation_Cohort 2 | 2 | Participants | ||
| Overall Response Rate (ORR) With Tenalisib and Romidepsin Combination | Dose escalation_Cohort 3 | 0 | Participants | ||
| Overall Response Rate (ORR) With Tenalisib and Romidepsin Combination | Dose expansion_Group 1 (PTCL) | 7 | Participants | ||
| Overall Response Rate (ORR) With Tenalisib and Romidepsin Combination | Dose expansion_Group 2 (CTCL) | 6 | Participants | ||
| Duration of Response (DoR) With Tenalisib and Romidepsin Combination | Dose escalation_Cohort 1 | 151 | 95% Confidence Interval 65 to 151 | days | |
| Duration of Response (DoR) With Tenalisib and Romidepsin Combination | Dose escalation_Cohort 2 | 151 | 95% Confidence Interval 65 to 151 | days | |
| Duration of Response (DoR) With Tenalisib and Romidepsin Combination | Dose expansion_Group1 (PTCL Patients) | 151 | 95% Confidence Interval 65 to 151 | days | |
| Duration of Response (DoR) With Tenalisib and Romidepsin Combination | Dose expansion_Group2 (CTCL Patients) | 114 | 95% Confidence Interval 57 to 114 | days | |
| Maximum Observed Plasma Concentration (Cmax) | Dose escalation_Cohort 1 | 1544.42 | Standard Deviation 1609.44 | nanogram/millilitre |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03770000/results